The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab.
Carvalho B, Lopes JM, Silva R, Peixoto J, Leitão D, Soares P, Fernandes AC, Linhares P, Vaz R, Lima J.
Carvalho B, et al. Among authors: lima j.
Sci Rep. 2021 Mar 16;11(1):6067. doi: 10.1038/s41598-021-85385-1.
Sci Rep. 2021.
PMID: 33727583
Free PMC article.
Clinical Trial.